| scholarly article | Q13442814 |
| P356 | DOI | 10.1309/K5P2-4Y8B-7L5A-FAA9 |
| P698 | PubMed publication ID | 11447756 |
| P2093 | author name string | Mihatsch MJ | |
| Sauter G | |||
| Gasser TC | |||
| Dalquen P | |||
| Grilli B | |||
| Bubendorf L | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fish | Q152 |
| bladder cancer | Q504775 | ||
| P304 | page(s) | 79-86 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | American Journal of Clinical Pathology | Q15750224 |
| P1476 | title | Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings | |
| P478 | volume | 116 |
| Q37680812 | "FISHing" to detect urinary and other cancers: validation of an imaging system to aid in interpretation |
| Q78368848 | A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens |
| Q36340124 | A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection |
| Q38032257 | A retrospective review of UroVysion fish interpretations over 8.6 years: a major shift in the patient test population. |
| Q79750687 | An evaluation of ThinPrep UroCyte filters for the preparation of slides for fluorescence in situ hybridization |
| Q36808420 | Biomarkers for detection and surveillance of bladder cancer. |
| Q36363221 | Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers |
| Q34016615 | Chromosomal aberrations in bladder cancer: fresh versus formalin fixed paraffin embedded tissue and targeted FISH versus wide microarray-based CGH analysis. |
| Q33962828 | Chromosomal imbalances in successive moments of human bladder urothelial carcinoma |
| Q83318588 | Clinical decisions for treatment of different staged bladder cancer based on multitarget fluorescence in situ hybridization assays? |
| Q81637608 | Combined analysis of morphology and fluorescence in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine samples |
| Q51297927 | Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma. |
| Q81505387 | Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology |
| Q80772883 | Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice |
| Q35075808 | Comparative study of ProEx C immunocytochemistry and UroVysion fluorescent in-situ hybridization assays on urine cytology specimens |
| Q48914536 | Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridization. |
| Q81729498 | Correlation between histologic findings and cytogenetic abnormalities in bladder carcinoma: a FISH study |
| Q44767925 | Cytology of the urinary tract. A modern investigation method? |
| Q78647106 | DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine |
| Q36418392 | DNA-based molecular cytology for bladder cancer surveillance |
| Q28245608 | Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer |
| Q37507532 | Diagnosis of urothelial carcinoma from urine |
| Q79456680 | Diagnostic Utility of the ImmunoCyt/uCyt+ Test in Bladder Cancer |
| Q37853965 | Digitized microscopy in the diagnosis of bladder cancer: analysis of >3000 cases during a 7-month period |
| Q47662071 | E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer |
| Q36791094 | Epigenetic markers for bladder cancer in urine |
| Q89011396 | Evaluation of Sienna Cancer Diagnostics hTERT Antibody on 500 Consecutive Urinary Tract Specimens |
| Q41839758 | Evaluation of a triple combination of cytokeratin 20, p53 and CD44 for improving detection of urothelial carcinoma in urine cytology specimens |
| Q84511413 | Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytology |
| Q73179683 | Evaluation of chromosome 8 and 11 aneuploidies in washings and biopsy materials of bladder transitional cell carcinoma |
| Q46304737 | Exclusion of the uniform tetraploid cells significantly improves specificity of the urine FISH assay |
| Q35154327 | FISH analysis of washing urine from the upper urinary tract for the detection of urothelial cancers |
| Q41597185 | Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette-Guérin therapy for intermediate- and high-risk non-muscle-invasive bladder cancer |
| Q34361348 | Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study |
| Q59801163 | Fluorescence in situ hybridization in 1 mL of selective urine for the detection of upper tract urothelial carcinoma: a feasibility study |
| Q82339590 | Fluorescence in situ hybridization in the diagnosis of urothelial carcinoma |
| Q33688552 | Fluorescence in situ hybridization status of voided urine predicts invasive and high-grade upper tract urothelial carcinoma |
| Q84795934 | Individual risk assessment in bladder cancer patients based on a multi-marker panel |
| Q33570471 | Integrating a FISH imaging system into the cytology laboratory |
| Q35643640 | Interaction network analysis of differentially expressed genes and screening of cancer marker in the urine of patients with invasive bladder cancer. |
| Q52001235 | Intermediate-risk urothelial carcinoma: an unresolved problem? |
| Q33202016 | Laser scanning cytometry for the detection of neoplasia in urologic cytology specimens |
| Q35226691 | MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarrays |
| Q53076839 | Molecular and Immunohistologic Analyses Cannot Reliably Solve Diagnostic Variation of Flat Intraepithelial Lesions of the Urinary Bladder |
| Q53239118 | Molecular characteristics of urothelial neoplasms in children and young adults: a subset of tumors from young patients harbors chromosomal abnormalities but not FGFR3 or TP53 gene mutations. |
| Q37671590 | Molecular screening for bladder cancer: progress and potential. |
| Q42789821 | Multiprobe fluorescence in situ hybridisation: prognostic perspectives in superficial bladder cancer |
| Q36669980 | Nucleic acid-based marker approaches to urologic cancers |
| Q81917685 | Possible malignancy after cytology analysis in a 45-year-old man |
| Q35720587 | Primary care update on kidney and bladder cancer: a urologic perspective |
| Q35219041 | Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer. |
| Q46839842 | Prognostic significance of nondiagnostic molecular changes in urine detected by UroVysion fluorescence in situ hybridization during surveillance for bladder cancer |
| Q33686437 | Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinoma |
| Q37151110 | Quantitative fluorescence in situ hybridization and its ability to predict bladder cancer recurrence and progression to muscle-invasive bladder cancer |
| Q83612735 | Reflex UroVysion testing in suspicious urine cytology cases |
| Q33798779 | Screening and identification of specific markers for bladder transitional cell carcinoma from urine urothelial cells with suppressive subtractive hybridization and cDNA microarray |
| Q35790135 | The development of a fluorescence in situ hybridization assay for the detection of dysplasia and adenocarcinoma in Barrett's esophagus |
| Q35782652 | The fascinating story of urine examination: From uroscopy to the era of microscopy and beyond |
| Q81204170 | The predictive value of multi-targeted fluorescent in-situ hybridization in patients with history of bladder cancer |
| Q57989694 | The use of Urovysion™ fluorescence in situ hybridization in the diagnosis and surveillance of non-urothelial carcinoma of the bladder |
| Q37417967 | The utility of fluorescence in situ hybridization for detection of bladder urothelial carcinoma in routine clinical practice |
| Q48292323 | The value of the UroVysion® FISH assay in the risk-stratification of patients with "atypical urothelial cells" in urinary cytology specimens |
| Q84449498 | The value of the preoperative FISH test in unscreened bladder cancer patients with TUR indications |
| Q36177679 | Urine and bladder washing cytology for detection of urothelial carcinoma: standard test with new possibilities |
| Q34073973 | Urine cytology and adjunct markers for detection and surveillance of bladder cancer |
| Q45374139 | UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing |
| Q84615556 | UroVysion, Urine Cytology, and the College of American Pathologists: Where Should We Go From Here? |
| Q35753968 | Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Guérin therapy for bladder cancer: results of a prospective trial |
| Q51980809 | [Cytology in the internet]. |
| Q84700981 | [Cytology of the urinary tract: Between uncertainty and clarity] |
| Q81369913 | [Fluorescence cystoscopy. Perspective in clinical practice and research] |
| Q80695356 | [Fluorescence in situ hybridization. A new diagnostic dimension in cytology] |
| Q83353070 | [Tumor marker tests in bladder cancer] |
| Q84131235 | [Urine-based tumour diagnostics for bladder cancer: effects of the new histopathological classification--food for thought] |
Search more.